Tri-moxi+¿ (triamcinolone recalls
The FDA has published 1 recall involving Tri-moxi+¿ (triamcinolone since 2026. The latest was reported on 14 Jan 2026. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 14 Jan 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why tri-moxi+¿ (triamcinolone is recalled
Companies
By year
Ongoing tri-moxi+¿ (triamcinolone recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tri-Moxi+¿ (Triamcinolone 9mg recalled by Imprimis NJOF | Imprimis Njof | Particulate Matter | Nationwide |
All tri-moxi+¿ (triamcinolone recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tri-Moxi+¿ (Triamcinolone 9mg recalled by Imprimis NJOF | Imprimis Njof | Particulate Matter | Nationwide |
Should you stop taking Tri-moxi+¿ (triamcinolone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.